Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Current Assets (2013 - 2026)

Updated

Lakefront Biotherapeutics' Current Assets was $3.58 billion in the quarter ended Mar 31, 2026, down 1.9% from $3.65 billion a year earlier and unchanged from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Current Assets (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Current Assets at Lakefront Biotherapeutics came in at $3.48 billion, down 3.7% from the prior year.

  • Current Assets has now declined for five consecutive years, with a five-year compound annual growth rate of -77.6% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Current Assets was $3.61 billion in the year ended Dec 31, 2024 (-13.0%), $4.15 billion in the year ended Dec 31, 2023 (-99.9%), $4.47 trillion in the year ended Dec 31, 2022 (-22.4%) and $5.75 trillion in the year ended Dec 31, 2021 (-6.2%).
  • The figure for the quarter ended Mar 31, 2026 marks the lowest quarterly Current Assets since the quarter ended Dec 31, 2024.
  • Compared with a year earlier, Current Assets was higher in 1 of the last six quarters, with an average decline of 6.9%.
  • The best year-over-year quarter for Current Assets over five years was the quarter ended Dec 31, 2025 (growth of 0.5%); the worst was the quarter ended Dec 31, 2023 (a decline of 99.9%).
  • Per Business Quant data, LKFT's Current Assets in the three quarters before the quarter ended Mar 31, 2026 was $3.58 billion (quarter ended Dec 31, 2025), $3.7 billion (quarter ended Sep 30, 2025) and $3.68 billion (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.58 Bn
Dec 31, 2025 3.58 Bn
Sep 30, 2025 3.70 Bn
Jun 30, 2025 3.68 Bn
Mar 31, 2025 3.65 Bn
Dec 31, 2024 3.57 Bn
Sep 30, 2024 3.91 Bn
Mar 31, 2024 4.11 Bn
Dec 31, 2023 4.15 Bn
Sep 30, 2023 4.31 Bn
Mar 31, 2023 4.46 Bn
Dec 31, 2022 4,322.64 Bn
Mar 31, 2022 5.33 Bn
Dec 31, 2021 5,561.82 Bn
Jun 30, 2021 6.18 Bn
Dec 31, 2020 6,401.82 Bn
Jun 30, 2020 6.19 Bn
Mar 31, 2020 6.38 Bn
Dec 31, 2019 6.49 Bn
Sep 30, 2019 6.29 Bn
API Access

Lakefront Biotherapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=LKFT&period=max&api_key=YOUR_API_KEY